Rollin Say
Papers
2
Total Citations
70
H-Index
2
About
Rollin Say is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for urologic cancers, with a particular focus on upper tract urothelial carcinoma (UTUC) and renal cell carcinoma. His major contributions include leading the ROBUUST Collaboration study, which identified key risk factors for intravesical recurrence after robotic nephroureterectomy—a critical issue affecting 20–50% of UTUC patients. This work, cited 45 times, provides evidence-based guidance for postoperative surveillance and has helped standardize outcomes across robotic, laparoscopic, and open approaches. Say also pioneered the concept of ambulatory robotic-assisted partial nephrectomy, demonstrating in a 25-cited study that select patients can safely undergo same-day discharge after kidney-sparing surgery, challenging traditional inpatient protocols and reducing healthcare costs. His research has been instrumental in refining perioperative care pathways and improving oncologic outcomes through collaborative, multi-institutional efforts. Say’s work is widely recognized for its practical impact on surgical decision-making and patient recovery, making him a leading voice in the evolution of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2